These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 22365517
1. Adjuvant chemotherapy for soft tissue sarcomas. Ravi V, Patel S. Surg Oncol Clin N Am; 2012 Apr; 21(2):243-53. PubMed ID: 22365517 [Abstract] [Full Text] [Related]
2. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Schuetze SM, Patel S. Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770 [Abstract] [Full Text] [Related]
3. New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas. Ferrari A, Casanova M. Expert Rev Anticancer Ther; 2005 Apr; 5(2):307-18. PubMed ID: 15877527 [Abstract] [Full Text] [Related]
4. [Adjuvant chemotherapy in the treatment of sarcomas]. Fayette J, Blay JY. Bull Cancer; 2006 Mar 01; 93(3):257-61. PubMed ID: 16567312 [Abstract] [Full Text] [Related]
5. Appraising the current role of chemotherapy for the treatment of sarcoma. D'Adamo DR. Semin Oncol; 2011 Oct 01; 38 Suppl 3():S19-29. PubMed ID: 22055968 [Abstract] [Full Text] [Related]
6. Relationship between doxorubicin binding ability and tumor volume decrease after chemotherapy in adult malignant soft tissue tumors in the extremities. Kusuzaki K, Shinjo H, Murata H, Takeshita H, Hashiguchi S, Nozaki T, Emoto K, Ashihara T, Hirasawa Y. Anticancer Res; 2000 Oct 01; 20(5C):3813-6. PubMed ID: 11268459 [Abstract] [Full Text] [Related]
7. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Karavasilis V, Seddon BM, Ashley S, Al-Muderis O, Fisher C, Judson I. Cancer; 2008 Apr 01; 112(7):1585-91. PubMed ID: 18278813 [Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven. Blay JY, Le Cesne A. Oncologist; 2009 Oct 01; 14(10):1013-20. PubMed ID: 19808771 [Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy for soft tissue sarcomas. Mertens WC, Bramwell VH. Hematol Oncol Clin North Am; 1995 Aug 01; 9(4):801-15. PubMed ID: 7490242 [Abstract] [Full Text] [Related]
10. The value of adjuvant chemotherapy in the management of sarcomas in children. Donaldson SS. Cancer; 1985 May 01; 55(9 Suppl):2184-97. PubMed ID: 3884137 [Abstract] [Full Text] [Related]
11. Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas. Scurr M, Judson I. Hematol Oncol Clin North Am; 2005 Jun 01; 19(3):489-500, vi. PubMed ID: 15939193 [Abstract] [Full Text] [Related]
16. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials]. Budach V. Strahlenther Onkol; 1996 Jul 01; 172(7):403-4. PubMed ID: 8693407 [No Abstract] [Full Text] [Related]
17. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Tsuchiya H, Tomita K, Yamamoto N, Mori Y, Asada N. Anticancer Res; 1998 Jul 01; 18(5B):3651-6. PubMed ID: 9854472 [Abstract] [Full Text] [Related]
18. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Lejeune FJ, Pujol N, Liénard D, Mosimann F, Raffoul W, Genton A, Guillou L, Landry M, Chassot PG, Chiolero R, Bischof-Delaloye A, Leyvraz S, Mirimanoff RO, Bejkos D, Leyvraz PF. Eur J Surg Oncol; 2000 Nov 01; 26(7):669-78. PubMed ID: 11078614 [Abstract] [Full Text] [Related]
19. Adjuvant therapy of sarcomas of soft tissue. Antman KH. Semin Oncol; 1997 Oct 01; 24(5):556-60. PubMed ID: 9344322 [Abstract] [Full Text] [Related]
20. Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients. Kasper B, Dietrich S, Mechtersheimer G, Ho AD, Egerer G. Oncology; 2007 Oct 01; 73(1-2):58-64. PubMed ID: 18334832 [Abstract] [Full Text] [Related] Page: [Next] [New Search]